About
Platform
Products
bCap 1
eCap 1
Lab
Team
Partnering & Licensing
Careers
Openings
News
Contact
Dyno’s Eric Kelsic fills the tank in his quest for better AAV with a group of big-name supporters on board
Eric Kelsic recognized in Endpoints 20 under 40 list: The 20(+1) under 40 – Inside the next generation of biotech leaders
Dyno sketches tens of thousands of viable next-gen AAV capsids with the help of machine learning — paper
Roche turns to a Harvard upstart out of George Church’s lab to construct AAV 2.0 model vectors — a key part of building the gene therapy pipeline
Spun out of George Church’s lab, this biotech upstart is mapping the AAV universe for Novartis, Sarepta to gaze
